EichorEICHOR
Location: Indianapolis Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Indianapolis

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Handheld Point of Care Electro-Diagnostic Device
NA · Indiana University Health · Indiana University · NCT07223827A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Indiana University Melvin and Bren Simon Cancer Center · Eli Lilly and Company · NCT07218380Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Indiana University School of Medicine · Arkansas Children's Hospital Research Institute · NCT03827694Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Phase 4 · Riley Hospital for Children · Indiana University · NCT06982105MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Indiana University/Melvin and Bren Simon Cancer Center · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Riley Hospital for Children · National Cancer Institute (NCI) · NCT05099003Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 8142 · Galderma R&D · NCT06988605Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Phase 1/Phase 2 · Indiana University Melvin and Bren Simon Comprehensive Cance · Indiana University · NCT06937866Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Riley Hospital for Children · National Cancer Institute (NCI) · NCT06172296Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Phase 1 · Riley Children's Hospital · New York Medical College · NCT04972942Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
NA · Price Vision Group · University of Miami · NCT06261346A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · Indiana Hemophilia & Thrombosis center · Hoffmann-La Roche · NCT05987449A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Riley Children's Hospital · Relay Therapeutics, Inc. · NCT06789913Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NA · Indiana University Health · Perspectum · NCT04054310A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Dawes Fretzin Clinical Research Group, LLC · Eli Lilly and Company · NCT06857942Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Phase 1 · Zydus US002 · Zydus Therapeutics Inc. · NCT05045482Measuring Patient Reported Needs in Outpatient Liver Disease Management
Phase N/A · Indiana University School of Medicine · Indiana University · NCT07191886High vs Low-frequency of High-intensity Training in Chronic Stroke
NA · Rehabilitation Hospital of Indiana · Indiana University · NCT06612723PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · Indiana University · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Indiana University School of Medicine · PedAL BCU, LLC · NCT05183035Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Community Health Network · CellCentric Ltd. · NCT04068597A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Riley Hospital for Children · Children's Oncology Group · NCT06368817Registry for Stage 2 Type 1 Diabetes
Phase N/A · Indiana University Health Riley Hospital for Children- Site · Sanofi · NCT06481904A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Riley Hospital for Children · National Cancer Institute (NCI) · NCT05691478Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832MCJR Joint Replacement Clinical Outcomes Database
Phase N/A · Midwest Center for Joint Replacement · Midwest Center for Joint Replacement · NCT03328611Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · Indiana University Melvin and Bren Simon Cancer Center · Greg Durm, MD · NCT04317534A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · LASSI - Laser and Skin Surgery Center of Indiana · Ipsen · NCT07435428A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · Innovative Hematology, Inc./Indiana Hemophilia and Thrombosi · Hemab ApS · NCT06754852Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Franciscan Health · Eli Lilly and Company · NCT06890598
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.